相关产品推荐更多 >

重组新冠病毒 FY.4 Spike S1+S2 trimer 蛋白 (ECD,His 标签)
¥5820
新冠病毒B.1.617.1 Spike S1+S2三聚体蛋白
¥5820
Influenza A H5N1 (A/Bangladesh/207095/2008) Hemagglutinin / HA Protein (His Tag)
¥4520
重组甲型流感 H5N1 Hemagglutinin/HA蛋白
¥4520
Hemagglutinin/HA重组蛋白|Recombinant Influenza A H1N1(A/Wisconsin/67/2022)HA Protein (aa 18-520,His Tag)
¥4520
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 询价记录
- 文献和实验
- 技术资料
- 保存条件:
-20℃ to -80℃
- 保质期:
12个月
- 英文名:
Recombinant SARS-CoV-2 (2019-nCoV) Spike RBD Recombinant Protein
- 库存:
99
- 供应商:
北京义翘神州科技股份有限公司
- 规格:
1.00 mg/100.00 µg
| 规格: | 1.00 mg | 产品价格: | ¥37830.0 |
|---|---|---|---|
| 规格: | 100.00 µg | 产品价格: | ¥4500.0 |
新冠病毒S RBD蛋白具有如下的特点:
1. 新冠病毒S RBD蛋白有编码SARS-COV-2 spike protein的RBD片段基因(YP_009724390.1) (Arg319-Phe541)表达。不带标签。
2. 新冠病毒S RBD蛋白经SDS-PAGE电泳检测,蛋白纯度> 95 %。
3. 新冠病毒S RBD蛋白利用LAL方法检测,内毒素含量低于1.0 EU/μg 。
4. 新冠病毒S RBD蛋白由HEK293细胞表达,接近天然结构,活性高。
5. 新冠病毒S RBD蛋白活性检测结果显示,蛋白具有良好的ACE2结合活性。
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
- 作者
- 内容
- 询问日期
文献和实验2, Kramer KJ, et al. Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition.Cell reports, PubMed ID: 34592170
3, Gebre MS, et al. Optimization of Non-Coding Regions for a Non-Modified mRNA COVID-19 Vaccine.Nature, PubMed ID: 34794169
4, Alameh MG, et al. Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses.Immunity, PubMed ID: 34852217
5, Kurmangali A, et al. Sensitive Detection of SARS-CoV-2 Variants Using an Electrochemical Impedance Spectroscopy Based Aptasensor.International journal of molecular sciences, PubMed ID: 36361926
6, Wang H, et al. Establishment of angiotensin-converting enzyme 2 and cluster of differentiation 147 dual target cell membrane chromatography based on SNAP-tag technology for screening anti severe acute respiratory syndrome coronavirus 2 active components.Journal of chromatography. A, PubMed ID: 36870232
7, Gary EN, et al. Adenosine deaminase augments SARS-CoV-2 specific cellular and humoral responses in aged mouse models of immunization and challenge.Frontiers in immunology, PubMed ID: 36999023
8, Ozawa T, et al. Rational in silico design identifies two mutations that restore UT28K SARS-CoV-2 monoclonal antibody activity against Omicron BA.1.Structure (London, England : 1993), PubMed ID: 38228146
Targeted RNA recombination has proven to be a powerful tool for the genetic engineering of the coronavirus genome, particularly in its 3′ part. Here we describe procedures for the generation of recombinant and mutant mouse hepatitis virus
Science:老药新用,研究发现癌症药物马赛替尼可有效对抗
近日,来自芝加哥大学的研究团队在 Science 上发表了一篇题为 Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2 的文章。该研究结果表明,酪氨酸酶抑制剂马赛替尼在抑制新冠病毒复制活性,减轻肺部炎症方面有显著的效果,并且体外实验表明马赛替尼对于新冠病毒的多种变种(B.1.1.7, B.1.351 and P.1)也具有作用。图片来源:Science研究内容随着全球疫苗
of PBS-T/BSA with more specialized solutions in serologic assays for antibodies against the RBD of SARS-CoV-2 (Fig. 5). While the signal intensity in a positive sample is comparable, background from negative samples - serum samples taken






